Chatham House Report Concludes That Changing Hygiene Behaviors Can Lead to Better Health, for the Individual, the Wider Population, and the Economy
A lack of safe water, sanitation, and hygiene results not only in loss of dignity, safety, health, and education, but also economic potential. It is at the heart of “human capital,” not only for the current working generation, but for generations to come. However, the subject of hygiene has never been near the top of the political agenda, something that needs to change. More global efforts are needed to link hygiene with policy-influencing outcomes and establish return on investment (ROI) to drive policy change. While it is evident that progress is being made on an international basis, more still needs to be done.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221109005660/en/
Driving hygiene behaviors – essential elements of universal healthcare? (Photo: Business Wire)
This was the conclusion from an assembled group of 32 experts in their respective fields within health and health policy, many of them from low-and middle- income countries (LMICs), during a round table discussion organized and facilitated by Reckitt Global Health Institute (RGHI) and global think tank Chatham House. The discussions took place under Chatham House’s Commission for Universal Health, which is on its agenda until 2024, and jointly chaired by Helen Clark, the former prime minister of New Zealand, and Jakaya Kikwete, former president of Tanzania.
The group had been invited to discuss a variety of fundamental topics in the forum, Driving hygiene behaviors – essential elements of universal healthcare? The discussion took place under the Chatham House Rule. Participants are free to use the information received, but neither the identity nor the affiliation of the speaker(s), nor that of any other participant, may be revealed.
The panel of experts, which included politicians, policymakers, academics, physicians, behavior change experts, and others representing international charities and Ministries of Health concluded that investments are needed beyond research. Firstly, to build workable, scalable hygiene interventions, and secondly to build ‘customer demand’ from communities that will put pressure on governments to supply hygiene infrastructure.
Simon Sinclair, Executive Director of RGHI said: “Defining and quantifying the impact of hygiene measures, and learning how to implement them at scale, is imperative if hygiene is to be built successfully into national health systems.”
The group conceded that while hygiene will always be included within the WASH community, there is an increasingly urgent need to strengthen its presence to ensure areas such as menstrual and respiratory hygiene have a place within the conversation at national levels. Building a universal understanding of the wider scope of ‘hygiene’ is essential. Hygiene needs to be seen as an essential part of the connected universal healthcare agenda.
Developments in pharmaceutical options in the 20th through to 21st centuries have diluted the focus on basic hygiene as an intervention. The recent emergence of novel coronaviruses causing SARS, MERS, and COVID, and the lack of immediate pharmaceutical solutions, has brought hygiene sharply to the front of our minds once again. While the emphasis of conventional hygiene practices has been on fecal-oral diseases, the COVID pandemic has prompted a focus on respiratory hygiene practices beyond handwashing/keeping clean and relevant to transmission of acute respiratory infections (ARIs).
Simon Sinclair continued “Global community leaders have work ahead of them to expand access to good hygiene. The UN has set access to clean water, sanitation, and hygiene as a sustainable development goal, but sound sanitation services reached little more than half the world’s population as of 2020. While hygiene has long been seen as beneficial to health, it now needs to be understood as a connected part of the basic requirements in building national health systems.”
The investment case for making hygiene a critical element of universal health was a pivotal part of the conversation and a call to action going forward.
Notes to editors:
To download the report: RGHI website
RGHI, a not-for-profit foundation, was established in 2020 with a multi-year $25 million grant from Reckitt. RGHI is focused on plugging significant gaps in the health research space and improving access to information that will bridge epidemiology, public health, and behaviour change.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005660/en/
Contact information
To arrange an interview with RGHI / Chatham House
Sarah Roberts
sarah_r@mail.rghi.org
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
